CPBTD
XBI icon

Central Pacific Bank - Trust Division’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.05K Buy
32
+2
+7% +$316 ﹤0.01% 734
2026
Q2 		$4.75K Buy
30
+3
+11% +$406 ﹤0.01% 749
2026
Q1 		$3.45K Hold
27
– – ﹤0.01% 753
2025
Q4 		$3.29K Buy
27
+11
+69% +$1.26K ﹤0.01% 747
2025
Q3 		$1.6K Hold
16
– – ﹤0.01% 791
2025
Q2 		$1.33K Hold
16
– – ﹤0.01% 803
2025
Q1 		$1.3K Hold
16
– – ﹤0.01% 808
2024
Q4 		$1.44K Hold
16
– – ﹤0.01% 832
2024
Q3 		$1.58K Hold
16
– – ﹤0.01% 804
2024
Q2 		$1.48K Hold
16
– – ﹤0.01% 892
2024
Q1 		$1.5K Buy
+16
New +$1.49K ﹤0.01% 889

Other funds holding XBI

LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
AIC
Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
MAM
Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

Central Pacific Bank - Trust Division's XBI Position: Q3 2026 in Review

Central Pacific Bank - Trust Division increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6.7% in Q3 2026, buying an estimated $316 and bringing the position to 32 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Central Pacific Bank - Trust Division first reported a position in XBI in Q1 2024 and has held it in 11 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Central Pacific Bank - Trust Division held 32 shares of State Street SPDR S&P Biotech ETF worth $5.05K as of Q3 2026.
  • Central Pacific Bank - Trust Division bought 2 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $316.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #734 holding.
  • Central Pacific Bank - Trust Division first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 11 quarters since.
  • 39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.